• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Remibrutinib Relieves Itching and Hives in Chronic Spontaneous Urticaria

byAstrid BradshawandAlisha Yi
March 19, 2025
in StudyGraphics
Reading Time: 1 min read
0
Share on FacebookShare on Twitter

Click here to read this study in NEJM. 

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

RELATED REPORTS

Safety of investigational vaccines against human immunodeficiency virus

Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines

#VisualAbstract: Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

Tags: chronic spontaneous urticariahivespruritisRemibrutiniburticaria
Previous Post

The Scan by 2 Minute Medicine®: Measles Outbreak, Tariffs and Healthcare, Pope’s Pneumonia, and Removing Fluoride from Water:

Next Post

Venetoclax plus azacitidine demonstrating efficacy for high-risk myelodysplastic syndromes

RelatedReports

Combined immunotherapy may improve survival in metastatic pancreatic cancer
Infectious Disease

Safety of investigational vaccines against human immunodeficiency virus

April 29, 2025
Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain
Chronic Disease

Remibrutinib alleviates symptoms in chronic spontaneous urticaria resistant to H1-antihistamines

March 13, 2025
#VisualAbstract: Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
StudyGraphics

#VisualAbstract: Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

October 31, 2023
#VisualAbstract: Serum antibody testing for SARS-CoV-2
StudyGraphics

#VisualAbstract: Nemolizumab for pruritis in atopic dermatitis patients

August 14, 2020
Next Post
Thrombophilia-associated stillbirth risk appears limited to factor V Leiden

Venetoclax plus azacitidine demonstrating efficacy for high-risk myelodysplastic syndromes

The 2 Minute Medicine Podcast Episode 15

The 2 Minute Medicine Podcast Episode 54

#VisualAbstract: No Differences in Liberal vs. Restrictive Red-Cell Transfusion Strategy in Aneurys-mal Subarachnoid Hemorrhage

#VisualAbstract: No Differences in Liberal vs. Restrictive Red-Cell Transfusion Strategy in Aneurys-mal Subarachnoid Hemorrhage

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The Scan by 2 Minute Medicine®: Climate-Driven Crises, Serena’s Mental Fitness Revolution, Superhuman Immunity, and Healthcare on Strike
  • AI-Powered Stethoscope Could Diagnose Heart Disease in Minutes
  • #VisualAbstract: DPP-1 Inhibitor Brensocatib Improves Outcomes in Bronchiectasis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.